Category Archives: Type-2 diabetes

Navigating GLP-1 Costs: Insurance, Savings, and Coverage

Meta Description: GLP-1 medications are effective but costly. Learn how to navigate insurance prior authorizations (PA), manufacturer savings programs, and […]

Read More

Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity

Introduction In ATTAIN-2, orforglipron met the primary and all key secondary endpoints, with compelling efficacy results and a safety profile consistent […]

Read More